Clinlogix Release: From Bench to Bedside: the Innovation Pathway
Published: Apr 30, 2013
JeanMarie will be presenting on the topic of “From Bench to Bedside: The Innovation Pathway" on Thursday, June 13th explaining the challenges in navigating investigational products through concept to approval (bench to bedside). The presentation will focus on topics such as Innovation vs. Regulatory Pathways, Proof of Concept, Validation Phases and Case Studies.
JeanMarie Markham, RN, CCRA, has over 20 years of experience in the industry. In 1999, JeanMarie founded Clinlogix, a Clinical Research Service Organization, with the primary goal of facilitating and accelerating the clinical development process for life science companies from early stage through post marketing by executing well thought out, cost-effective solutions.
JeanMarie stated that “There is an increasing desire to conduct clinical trials on a global scale. Many countries have their own regulatory body making multi-country trials increasingly difficult and time consuming. I appreciate the opportunity to present our views at this conference.”
Clinlogix, a clinical research organization, provides comprehensive clinical development services for pharmaceutical, biotech and medical device companies engaged in clinical programs. A global service provider founded in 1999, Clinlogix supports and services clinical development of medical devices, pharmaceuticals, biologics and diagnostics from early stage and Phase I through post marketing, complying with worldwide regulatory requirements. Clients choose either full-service clinical development or functional services to fit their specific needs. Certified by the Women’s Business Enterprise National Council, Clinlogix succeeds in delivering quality and compliant results, on time and on budget. For more information, please visit http://www.clinlogix.com/.